The interaction of chemistry, biology, DMPK, and in vivo pharmacology with one CRO has been difficult to achieve to date. Discovery from Charles River has established a unique platform that blends all scientific disciplines to support the development of projects from target validation through to candidate nomination.
This talk highlights platforms and technologies currently employed by Discovery from Charles River and provides support via case studies detailing the collaborations that led to the delivery of clinical candidates for our partners.
- Martin O’Rourke, PhD, Director, In Vitro Biosciences, Charles River
Please see the links below for the other webinars from the Charles River and AstraZeneca Oncology Partnership Day: